SAN DIEGO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (NASDAQ: SKYE) (“Skye” or the “Company”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for metabolic health, today reported financial results for the third quarter ended September 30, 2024, and highlighted recent corporate achievements.
Read more at globenewswire.comSkye Bioscience Reports Third Quarter 2024 Financial Results and Recent Highlights
SKYE BIOSCIENCE INC
NASDAQ:SKYE (2/11/2025, 8:00:01 PM)
After market: 2.98 +0.09 (+3.11%)2.89
-0.54 (-15.74%)
SKYE Latest News and Analysis
12 hours ago - ChartmillTuesday's session: top gainers and losersIntrigued by the market activity one hour before the close of the markets on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
